Skip to content
Review Open access

Phage-directed precision microbiome medicine: engineering pathobiont depletion, synbiotic succession, microbial-function editing, metabolite host signaling, neurophagomics, and durable ecological state control in gut dysbiosis associated diseases

Oct 2026 · Frontiers in Microbiology · Vol 17 · 0 citations · 82 references
Medicine

TL;DR

Clinical development will require reproducible good manufacturing practice, control of endotoxin and host-cell contaminants, product stability, resistance and immune-neutralization monitoring, environmental-shedding assessment, and regulatory strategies for genetically modified, dynamically updated, and multi-component products.

Abstract

Bacteriophages are being investigated as strain-selective tools for modifying intestinal microbial communities, but the evidence supporting ecological reconstruction is substantially less mature than the evidence supporting targeted bacterial depletion. This review separates current knowledge into three domains: established and emerging experimental evidence, human translational evidence, and hypotheses proposed for future testing. Human studies show that orally administered natural or engineered phages can be recovered from the gastrointestinal tract and can alter selected bacterial populations without antibiotic-like loss of overall community diversity. Preclinical studies further demonstrate targeted suppression of inflammatory Klebsiella pneumoniae in inflammatory bowel disease models, cytolytic Enterococcus faecalis in alcohol-associated liver disease, evolutionary steering of Escherichia coli, in situ bacterial genome editing, local therapeutic-protein production, and phage-probiotic cooperation. These findings do not yet establish that an integrated phage-successor-prebiotic sequence can durably reprogram a human gut ecosystem. To organize this translational gap, we use Subtract-Seed-Feed-Lock as an explicitly proposed design framework. A phage or phage-derived platform first depletes, weakens, or edits a disease-relevant bacterial strain or function; a niche-matched successor is then introduced; a selectively utilized nutrient supports that successor; and durability is assessed after treatment withdrawal. Related terms used in this review—Functional Phageability, Minimum Ecological Dose, Ecological Vacancy Window, nutrient-conditioned phagogram, ecological pharmacokinetics/pharmacodynamics (Eco-PK/PD), ecological pharmacovigilance, neurophagomic reverse translation, and microbiome-state digital twin—are hypothesis-generating operational concepts rather than validated clinical methods. Host signaling is likewise framed as predominantly indirect: phage-induced changes in bacterial abundance or function may alter lipopolysaccharide, short-chain fatty acids, indoles, bile acids, and other metabolites that subsequently engage inflammatory, barrier, hepatic, or neural pathways. The gut-brain application remains especially preliminary; targeting urdA-positive imidazole-propionate producers has not been validated with therapeutic phages. Clinical development will require reproducible good manufacturing practice, control of endotoxin and host-cell contaminants, product stability, resistance and immune-neutralization monitoring, environmental-shedding assessment, and regulatory strategies for genetically modified, dynamically updated, and multi-component products. The immediate opportunity is therefore precise microbial perturbation with evidence-matched endpoints; durable programmed reconstruction remains an experimentally testable objective.

Read PDF

Similar papers

Review Open access Sep 2026

Post‐Microbial Therapeutics for the Next Generation of Medicine

Post‐microbial therapeutics is proposed here as an integrative, function‐centered framework rather than a new therapeutic class and is best viewed as a testable translational architecture that connects intervention to function and outcome while separating established evidence from emerging hypotheses.

M. N. I. Bhuiyan, Maliha Momtaj · 1 citation
Review Open access Sep 2026

Bioinformatic approaches to pig gut phagobiome (phageome) analysis: tools, applications, and current state of research

Abstract The pig intestine contains a diverse bacteriophage community that helps regulate the gut microbiome and host health. Growing interest in phage therapy reflects its potential as a cost-effective, targeted approach to modulating microbial communities and treating diseases, particularly those involving antibiotic...

Anna Miastowska, A. Augustyniak, Bartłomiej Grygorcewicz et al. · 0 citations
Open access Sep 2026

A microbiota-derived protease links phage susceptibility to host epithelial responses

Bacteriophages are major ecological drivers of gut microbial ecology, yet whether bacterial mechanisms that determine phage susceptibility have consequences for the mammalian host remains poorly understood. Here, we identify dipeptidyl peptidase 11 (Dpp11a), the predominant active serine protease of the prevalent gut c...

Ning Qu, Marlène S. Birk, Thomas C. A. Hitch et al. · 0 citations
Review Oct 2026

From ecosystem engineering to living computers: integrating dual-paradigm bacterial therapeutics for solid tumor microenvironment reprogramming.

Recent advances in tumor microbiome biology and synthetic biology have made bacteria attractive therapeutic agents capable of reprogramming tumor-associated microbial ecosystems and serving as programmable living systems in solid tumors. In this review, we construct a dual-paradigm framework combining engineered bacter...

A. Elmetwalli, Naseh A. Algehainy, F. Altemani et al. · 0 citations
Review Oct 2026

Gut bacterial-derived beneficial proteins in intestinal disease.

The human gut microbiota is a vast and intricate microbial ecosystem that plays indispensable roles in host physiology, including nutritional metabolism, immune system development, and disease prevention. While current research has extensively focused on microbiota-derived small-molecule metabolites and virulence-assoc...

Si-Yang Zhou, Qi-Cong Tian, Shafi Ullah et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.